Laboratory of Chemical Biology, Department of Biomedical Engineering and Institute for Complex Molecular Systems (ICMS), Eindhoven University of Technology, Den Dolech 2, 5612, AZ Eindhoven, The Netherlands.
Department of Pharmaceutical Chemistry and Small Molecule Discovery Centre (SMDC), University of California San Francisco (UCSF), San Francisco, CA, 94143, USA.
Angew Chem Int Ed Engl. 2023 Sep 11;62(37):e202308004. doi: 10.1002/anie.202308004. Epub 2023 Aug 1.
Small-molecule stabilization of protein-protein interactions (PPIs) is a promising strategy in chemical biology and drug discovery. However, the systematic discovery of PPI stabilizers remains a largely unmet challenge. Herein we report a fragment-linking approach targeting the interface of 14-3-3 and a peptide derived from the estrogen receptor alpha (ERα) protein. Two classes of fragments-a covalent and a noncovalent fragment-were co-crystallized and subsequently linked, resulting in a noncovalent hybrid molecule in which the original fragment interactions were largely conserved. Supported by 20 crystal structures, this initial hybrid molecule was further optimized, resulting in selective, 25-fold stabilization of the 14-3-3/ERα interaction. The high-resolution structures of both the single fragments, their co-crystal structures and those of the linked fragments document a feasible strategy to develop orthosteric PPI stabilizers by linking to an initial tethered fragment.
小分子稳定蛋白质-蛋白质相互作用(PPIs)是化学生物学和药物发现中很有前途的策略。然而,系统地发现 PPI 稳定剂仍然是一个尚未得到满足的挑战。在此,我们报告了一种针对 14-3-3 和源自雌激素受体α(ERα)蛋白的肽的界面的片段连接方法。两个类别的片段-共价和非共价片段-被共结晶,然后连接,得到一个非共价的混合分子,其中原始片段相互作用在很大程度上被保留。在 20 个晶体结构的支持下,对该初始混合分子进行了进一步优化,导致 14-3-3/ERα 相互作用的选择性、25 倍稳定化。单个片段的高分辨率结构、它们的共晶结构以及连接片段的结构证明了通过连接到初始连接片段来开发正位 PPI 稳定剂的可行策略。